(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists at the Universities ...
Nov 10, 2011
0
0
The FDA has announced the approval of Anascorp, the first drug designed to specifically treat and counteract the venomous stings of scorpions.
Researchers have detected anaerobic and aerobic bacteria in commercial tattoo and permanent makeup inks. The findings, reported in Applied and Environmental Microbiology demonstrate that the inks could be a source of human ...
Jul 2, 2024
0
0
Researchers at the University of Sydney and University of Geneva have developed a new anticoagulant, whose anticlotting action can be rapidly stopped "on demand." The result could lead to new surgical and post-operative drugs ...
Apr 30, 2024
0
32
The U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream ...
Apr 9, 2024
0
1
Tattoos are an incredibly common form of permanent self-expression that date back thousands of years. Most tattoo artists follow strict health and sanitation regulations, so you might assume that tattoo inks are carefully ...
Mar 23, 2024
0
1
Colorectal cancer is the third most common cancer worldwide, according to the World Health Organization, and a Kansas State University graduate student is doing research to identify and improve effective colon cancer care.
Mar 5, 2024
0
0
With several drug overdoses already this season, and recent news of three new recreational drugs identified by the drug checking service in Canberra, many parents of teenagers will be wondering how they can keep their kids ...
Jan 22, 2024
0
1
A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results.
Dec 21, 2023
0
2
The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.
Nov 8, 2023
0
0
